Table 1.
Demographic, clinical and laboratory findings of the study groups.
| Variables | Healthy control group (group 1) n = 40 |
Patient with hypertension and without pcos group (group 2) n = 40 |
Patient with hypertension and pcos group (group 3) n = 40 |
P |
|---|---|---|---|---|
| Age (year) | 28.0 ± 4.71 | 29.4 ± 3.84 | 29.2 ± 4.74 | .292 |
| Body mass index (kg/m2) | 23.3 ± 1.67* | 23.8 ± 3.48† | 27.5 ± 7.74 | .004 |
| Basal heart rate (pulse/minute) | 77.1 ± 7.38 | 80.1 ± 10.2 | 78.2 ± 9.70 | .387 |
| White blood cell (10³/µL) | 6.83 ± 1.65 | 6.19 ± 1.30 | 6.25 ± 1.45 | .213 |
| Hemoglobin (g/dL) |
12.8 ± 0.64 | 12.7 ± 0.89 | 13.0 ± 1.59 | .493 |
| Platelet (10³/µL) | 290.8 ± 36.1 | 296.9 ± 66.4 | 274.0 ± 67.2 | .221 |
| Creatinine (mg/dL) | 0.58 ± 0.13 | 0.58 ± 0.07 | 0.59 ± 0.08 | .863 |
| Sodium (mmol/L) | 139.0 ± 2.06 | 138.7 ± 1.07 | 138.8 ± 1.16 | .680 |
| Potassium (mmol/L) | 4.31 ± 0.35 | 4.40 ± 0.31 | 4.38 ± 0.30 | .519 |
| Aspartate aminotransferase (u/L) | 17.3 ± 5.86 | 19.3 ± 4.31 | 20.4 ± 8.14 | .103 |
| Alanine aminotransferase (u/L) | 16.3 ± 4.65* | 14.9 ± 6.52† | 19.4 ± 9.33 | .021 |
| Triglyceride (mg/dL) | 105.6 ± 40.4 | 117.1 ± 76.2 | 120.3 ± 73.0 | .573 |
| High-density lipoprotein (mg/dL) | 53.0 ± 12.0 | 54.0 ± 14.4 | 54.9 ± 14.5 | .834 |
| Low-density lipoprotein (mg/dL) | 119.0 ± 26.1 | 115.9 ± 20.7 | 123..3 ± 36.5 | .530 |
| Calcium (mg/dL) | 9.45 ± 0.52 | 9.64 ± 0.30 | 9.61 ± 0.35 | .130 |
| Glucose (mg/dL) | 98.4 ± 5.45 | 98.8 ± 8.77 | 102.9 ± 13.4 | .154 |
| Thyroid stimulating hormone (mIU/L) | 1.83 ± 0.80 | 1.98 ± 0.98 | 2.04 ± 1.06 | .630 |
| C-reactive protein (mg/L) | 0.18 ± 0.10 | 0.23 ± 0.20 | 0.21 ± 0.17 | .361 |
Bold values indicate significant P values.
Pcos = polycystic ovary syndrome.
*
The significant difference between group 1 and group 3.
†
The significant difference between group 2 and group 3.